Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Assessment of the circulating klotho protein in lung cancer patients.

Pako J, Bikov A, Barta I, Matsueda H, Puskas R, Galffy G, Kerpel-Fronius A, Antus B, Horvath I.

Pathol Oncol Res. 2018 Jun 12. doi: 10.1007/s12253-018-0441-5. [Epub ahead of print]

PMID:
29948618
2.

Improving Gene-Expression Studies from Sputum: A Multistep Optimization of RNA Isolation and qPCR Protocols.

Paska C, Barta I, Drozdovszky O, Antus B.

Am J Respir Cell Mol Biol. 2017 Nov;57(5):626-628. doi: 10.1165/rcmb.2017-0198LE. No abstract available.

PMID:
29090961
3.

Assessment of exhaled carbon monoxide in exacerbations of chronic obstructive pulmonary disease.

Antus B, Drozdovszky O, Barta I.

Physiol Int. 2016 Jun 1;103(2):211-219. doi: 10.1556/036.103.2016.2.8.

PMID:
28639864
4.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

PMID:
28446552
5.

Kinetics of Exhaled Carbon Monoxide After Water-pipe Smoking Indoors and Outdoors.

Juhasz A, Pap D, Barta I, Drozdovszky O, Egresi A, Antus B.

Chest. 2017 May;151(5):1051-1057. doi: 10.1016/j.chest.2017.02.006. Epub 2017 Feb 17.

PMID:
28215785
6.

Assessment of the Anti-Aging Klotho Protein in Patients with COPD Undergoing Pulmonary Rehabilitation.

Pako J, Barta I, Balogh Z, Kerti M, Drozdovszky O, Bikov A, Antus B, Horvath I, Varga J.

COPD. 2017 Apr;14(2):176-180. doi: 10.1080/15412555.2016.1272563. Epub 2017 Jan 23.

PMID:
28112974
7.

Oxidative Stress Markers in Sputum.

Antus B.

Oxid Med Cell Longev. 2016;2016:2930434. doi: 10.1155/2016/2930434. Epub 2016 Jan 14. Review.

8.

Response to the Letter Entitled "Comments Concerning Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis".

Antus B, Barta I.

Lung. 2015 Oct;193(5):861-2. doi: 10.1007/s00408-015-9785-8. Epub 2015 Aug 18. No abstract available.

PMID:
26283028
9.

Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis.

Antus B, Drozdovszky O, Barta I, Kelemen K.

Lung. 2015 Aug;193(4):597-604. doi: 10.1007/s00408-015-9739-1. Epub 2015 May 8.

PMID:
25951912
10.

Oxidative stress in COPD: molecular background and clinical monitoring.

Antus B, Kardos Z.

Curr Med Chem. 2015;22(5):627-50.

PMID:
25585265
11.

Sputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary disease.

Drozdovszky O, Barta I, Antus B.

Respiration. 2014;87(5):408-15. doi: 10.1159/000358099. Epub 2014 Apr 4.

12.

Exhaled breath condensate pH decreases during exercise-induced bronchoconstriction.

Bikov A, Galffy G, Tamasi L, Bartusek D, Antus B, Losonczy G, Horvath I.

Respirology. 2014 May;19(4):563-9. doi: 10.1111/resp.12248. Epub 2014 Feb 25.

13.

Relationship between exhaled nitric oxide and the frequency of severe acute exacerbation of COPD: 3-year follow-up.

Antus B, Barta I.

Acta Physiol Hung. 2013 Dec;100(4):469-77. doi: 10.1556/APhysiol.100.2013.016.

PMID:
24013942
14.

Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.

Antus B, Harnasi G, Drozdovszky O, Barta I.

Respirology. 2014 Jan;19(1):74-9. doi: 10.1111/resp.12155.

15.

Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.

Soter S, Barta I, Antus B.

Inflammation. 2013 Oct;36(5):1178-85. doi: 10.1007/s10753-013-9653-8.

PMID:
23681903
16.

[Clinical application of induced and spontaneous sputum in asthma and chronic obstructive pulmonary disease].

Antus B.

Orv Hetil. 2012 Nov 25;153(47):1847-54. doi: 10.1556/OH.2012.29494. Review. Hungarian.

PMID:
23160075
17.

Exhaled breath condensate pH in patients with cystic fibrosis.

Antus B, Barta I, Csiszer E, Kelemen K.

Inflamm Res. 2012 Oct;61(10):1141-7. doi: 10.1007/s00011-012-0508-9. Epub 2012 Jun 16.

PMID:
22706320
18.

[Assessment of airway inflammation in chronic obstructive pulmonary disease: biomarkers in exhaled breath condensate].

Antus B.

Orv Hetil. 2012 Jun 3;153(22):843-51. doi: 10.1556/OH.2012.29383. Review. Hungarian.

PMID:
22641258
19.

Exhaled nitric oxide in diagnosis of bronchiolitis obliterans syndrome in lung transplant recipients: possible limitations.

Antus B, Barta I, Csiszer E.

Am J Transplant. 2011 Dec;11(12):2774-5; author reply 2776-7. doi: 10.1111/j.1600-6143.2011.03780.x. Epub 2011 Nov 4. No abstract available.

20.

Exercise changes volatiles in exhaled breath assessed by an electronic nose.

Bikov A, Lazar Z, Schandl K, Antus BM, Losonczy G, Horvath I.

Acta Physiol Hung. 2011 Sep;98(3):321-8. doi: 10.1556/APhysiol.98.2011.3.9.

PMID:
21893471
21.

Exhaled breath condensate pH in patients with lung cancer.

Antus B, Barta I.

Lung Cancer. 2012 Feb;75(2):178-80. doi: 10.1016/j.lungcan.2011.07.007. Epub 2011 Aug 9.

PMID:
21831475
22.

Assessment of reproducibility of exhaled hydrogen peroxide concentration and the effect of breathing pattern in healthy subjects.

Gajdocsi R, Bikov A, Antus B, Horvath I, Barnes PJ, Kharitonov SA.

J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):271-5. doi: 10.1089/jamp.2011.0875. Epub 2011 Jun 20.

PMID:
21689021
23.

Exhaled breath condensate pH in lung transplant recipients with bronchiolitis obliterans syndrome.

Soter S, Kelemen K, Barta I, Valyon M, Csiszer E, Antus B.

Transplantation. 2011 Apr 15;91(7):793-7. doi: 10.1097/TP.0b013e31820d3bc3.

PMID:
21289593
24.

[Role of exhaled nitric oxide in predicting steroid response in chronic obstructive pulmonary disease].

Antus B.

Orv Hetil. 2010 Dec 19;151(51):2083-8. doi: 10.1556/OH.2010.28972. Review. Hungarian.

PMID:
21147678
25.

Exercise increases exhaled breath condensate cysteinyl leukotriene concentration in asthmatic patients.

Bikov A, Gajdócsi R, Huszár É, Szili B, Lázár Z, Antus B, Losonczy G, Horváth I.

J Asthma. 2010 Nov;47(9):1057-62. doi: 10.1080/02770903.2010.512690.

PMID:
20868319
26.

Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts.

Fillinger J, Antus B.

Exp Lung Res. 2010 Dec;36(10):625-31. doi: 10.3109/01902148.2010.499443. Epub 2010 Sep 23.

PMID:
20860540
27.

Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.

Antus B, Barta I, Kullmann T, Lazar Z, Valyon M, Horvath I, Csiszer E.

Am J Respir Crit Care Med. 2010 Dec 15;182(12):1492-7. doi: 10.1164/rccm.201003-0451OC. Epub 2010 Jul 23.

PMID:
20656939
28.

Assessment of exhaled nitric oxide by a new hand-held device.

Antus B, Horvath I, Barta I.

Respir Med. 2010 Sep;104(9):1377-80. doi: 10.1016/j.rmed.2010.06.005. Epub 2010 Jul 2.

29.

Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations.

Antus B, Barta I, Horvath I, Csiszer E.

Respirology. 2010 Apr;15(3):472-7. doi: 10.1111/j.1440-1843.2010.01711.x. Epub 2010 Feb 24.

PMID:
20210889
30.

Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma.

Barta I, Kullmann T, Csiszer E, Antus B.

Int J Biol Markers. 2010 Jan-Mar;25(1):52-6.

PMID:
20155714
31.

Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome.

Antus B, Barta I, Czebe K, Horvath I, Csiszer E.

Inflamm Res. 2010 Jan;59(1):83-6.

PMID:
20066781
32.

Adenosine triphosphate in exhaled breath condensate of healthy subjects and patients with chronic obstructive pulmonary disease.

Lázár Z, Huszár E, Kullmann T, Barta I, Antus B, Bikov A, Kollai M, Horváth I.

Inflamm Res. 2008 Aug;57(8):367-73. doi: 10.1007/s00011-008-8009-6.

PMID:
18787775
33.

Late treatment with angiotensin-converting enzyme inhibitors plus endothelin receptor antagonists ameliorates rat tracheal allograft rejection.

Antus B, Fillinger J, Sebe A, Jeney C, Horvath I.

Transpl Int. 2008 Aug;21(8):801-7. doi: 10.1111/j.1432-2277.2008.00693.x. Epub 2008 May 19.

34.

Differential cytokine pattern in the exhaled breath of patients with lung cancer.

Kullmann T, Barta I, Csiszér E, Antus B, Horváth I.

Pathol Oncol Res. 2008 Dec;14(4):481-3. doi: 10.1007/s12253-008-9046-8. Epub 2008 Apr 16.

PMID:
18415708
35.

Drinking influences exhaled breath condensate acidity.

Kullmann T, Barta I, Antus B, Horváth I.

Lung. 2008 Jul-Aug;186(4):263-268. doi: 10.1007/s00408-008-9086-6. Epub 2008 Mar 27.

PMID:
18368450
36.

Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations.

Czebe K, Barta I, Antus B, Valyon M, Horváth I, Kullmann T.

Respir Med. 2008 May;102(5):720-5. doi: 10.1016/j.rmed.2007.12.013. Epub 2008 Jan 31.

37.

Environmental temperature and relative humidity influence exhaled breath condensate pH.

Kullmann T, Barta I, Antus B, Valyon M, Horváth I.

Eur Respir J. 2008 Feb;31(2):474-5. doi: 10.1183/09031936.00128007. No abstract available. Erratum in: Eur Respir J. 2008 Apr;31(4):912.

38.

[Pulmonary infections after lung transplantation].

Czebe K, Antus B, Varga M, Csiszér E.

Orv Hetil. 2008 Jan 20;149(3):99-109. doi: 10.1556/OH.2008.28233. Review. Hungarian.

PMID:
18194917
39.

Exhaled nitric oxide and carbon monoxide in respiratory diseases.

Antus B, Horváth I.

J Breath Res. 2007 Dec;1(2):024002. doi: 10.1088/1752-7155/1/2/024002. Epub 2007 Dec 6.

PMID:
21383433
40.

Variability of exhaled breath condensate pH in lung transplant recipients.

Czebe K, Kullmann T, Csiszer E, Barat E, Horvath I, Antus B.

Respiration. 2008;75(3):322-7.

PMID:
18042977
41.

[New diagnostic method in pulmonary carcinoid].

Csiszér E, Antus B, Himber G, Hertel K, Fillinger J.

Magy Onkol. 2007;51(3):225-8. Epub 2007 Oct 7. Hungarian.

42.

[Exhaled nitric oxide in the diagnosis and monitoring of lung diseases].

Antus B, Horváth I.

Orv Hetil. 2007 Jul 8;148(27):1251-7. Review. Hungarian.

PMID:
17604261
43.

Effects of blockade of the renin-angiotensin and endothelin systems on experimental bronchiolitis obliterans.

Antus B, Sebe A, Fillinger J, Jeney C, Horvath I.

J Heart Lung Transplant. 2006 Nov;25(11):1324-9.

PMID:
17097496
44.

No gender difference in development of obliterative airway disease in rat tracheal allografts.

Antus B, Fillinger J, Sebe A, Jeney C, Soltesz I, Horvath I.

Exp Mol Pathol. 2006 Dec;81(3):235-8. Epub 2006 Jul 21.

PMID:
16859678
45.

Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy.

Lutz J, Risch K, Liu S, Antus B, Schmaderer C, Roos M, Ouyang N, Lehmann M, Heemann U.

Kidney Int. 2006 Sep;70(6):1080-8. Epub 2006 Jul 19.

46.

[Bronchiolitis obliterans syndrome in lung transplant recipients].

Antus B, Fillinger J, Csiszér E, Czebe K, Horváth I.

Orv Hetil. 2005 May 8;146(19):953-8. Review. Hungarian.

PMID:
15969307
47.

Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study.

Antus B, Csiszer E, Czebe K, Horvath I.

Clin Transplant. 2005 Jun;19(3):377-82.

PMID:
15877802
48.

Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats.

Lutz J, Yao Y, Song E, Antus B, Hamar P, Liu S, Heemann U.

Transplantation. 2005 Mar 27;79(6):655-61.

PMID:
15785371
49.

Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.

Antus B, Liu S, Yao Y, Zou H, Song E, Lutz J, Heemann U.

Nephrol Dial Transplant. 2005 Feb;20(2):329-35. Epub 2004 Dec 23.

PMID:
15618244
50.

Apoptosis and treatment of chronic allograft nephropathy with everolimus.

Lutz J, Zou H, Liu S, Antus B, Heemann U.

Transplantation. 2003 Aug 15;76(3):508-15.

PMID:
12923436

Supplemental Content

Support Center